RxDoctor Payments Data

Erica Baumgartner

Family · New Castle, INNPI 1801260898

Payments from drug & device makers

$3,167in general payments, 2019–2025

Across 210 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$800
  • Novo Nordisk$422
  • AstraZeneca$395
  • Lilly USA, LLC$201
  • Bayer$131
  • Boehringer Ingelheim$125
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,155100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,167 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$18,063
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,054
Albuterol Sulfate HfaAlbuterol Sulfate32$827
Doxycycline Hyclate44$312
Omeprazole26$292
Atorvastatin Calcium18$282
Duloxetine Hcl16$261
Buspirone Hcl19$259
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$247
Lisinopril37$221
Gabapentin21$209
Levothyroxine Sodium27$158
Prednisone69$155
Metformin Hcl11$116
Cephalexin12$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$125$18,06311 claims
GSKTrelegy Ellipta$106$9,05414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in New Castle

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →